Infection disclosure in the injecting dyads of Hungarian and Lithuanian injecting drug users who self-reported being infected with hepatitis C virus or human immunodeficiency virus

被引:12
|
作者
Anna Gyarmathy, V. [1 ,2 ]
Neaigus, Alan [3 ]
Li, Nan [2 ]
Ujhelyi, Eszter [4 ]
Caplinskiene, Irma [5 ,6 ]
Caplinskas, Saulius [5 ,6 ]
Latkin, Carl A. [2 ]
机构
[1] European Monitoring Ctr Drugs & Drug Addict, P-1249289 Lisbon, Portugal
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA
[4] Szent Laszlo Hosp, Budapest, Hungary
[5] Ctr Communicable Dis & AIDS, Vilnius, Lithuania
[6] M Romeris Univ, Social Policy Fac, Vilnius, Lithuania
关键词
RISK BEHAVIORS; HIV SEROSTATUS; PREVENTIVE BEHAVIOR; KNOWLEDGE; LONDON;
D O I
10.3109/00365548.2010.513064
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to assess the prevalence and correlates of disclosure to network members of being hepatitis C virus (HCV)- or human immunodeficiency virus (HIV)-infected among injecting dyads of infected injection drug users (IDUs) in Budapest, Hungary and Vilnius, Lithuania,. Multivariate generalized estimating equations (GEE) were used to assess associations. Very strong infection disclosure norms exist in Hungary, and HCV disclosure was associated with using drugs and having sex within the dyad. Non-ethnic Russian IDUs in Lithuania were more likely to disclose HCV infection to non-Roma, emotionally close and HCV-infected network members, and to those with whom they shared cookers, filters, drug solutions or rinse water or got used syringes from, and if they had fewer non-IDU or IDU network members. Ethnic Russian Lithuanian IDUs were more likely to disclose HCV if they had higher disclosure attitude and knowledge scores, 'trusted' network members, and had lower non-injecting network density and higher injecting network density. HIV-infected Lithuanian IDUs were more likely to disclose to 'trusted' network members. Disclosure norms matched disclosure behaviour in Hungary, while disclosure in Lithuania to 'trusted' network members suggests possible stigmatization. Ongoing free and confidential HCV/HIV testing services for IDUs are needed to emphasize and strengthen disclosure norms, and to decrease stigma.
引用
收藏
页码:32 / 42
页数:11
相关论文
共 14 条
  • [1] Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City
    Howe, CJ
    Fuller, CM
    Ompad, DC
    Galea, S
    Koblin, B
    Thomas, D
    Vlahov, D
    DRUG AND ALCOHOL DEPENDENCE, 2005, 79 (03) : 389 - 395
  • [2] Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: A cross-sectional study
    Camoni, Laura
    Regine, Vincenza
    Salfa, Maria C.
    Nicoletti, Giovanni
    Canuzzi, Pietro
    Magliocchetti, Natalia
    Rezza, Giovanni
    Suligoi, Barbara
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2009, 41 (6-7) : 520 - 523
  • [3] Modeling the effect of high dead-space syringes on the human immunodeficiency virus (HIV) epidemic among injecting drug users
    Bobashev, Georgiy V.
    Zule, William A.
    ADDICTION, 2010, 105 (08) : 1439 - 1447
  • [4] Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
    O'Keefe, Daniel
    Aitken, Campbell
    Higgs, Peter
    Dietze, Paul
    DRUG AND ALCOHOL REVIEW, 2013, 32 (02) : 208 - 210
  • [5] The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence
    Turner, Katy M. E.
    Hutchinson, Sharon
    Vickerman, Peter
    Hope, Vivian
    Craine, Noel
    Palmateer, Norah
    May, Margaret
    Taylor, Avril
    De Angelis, Daniela
    Cameron, Sheila
    Parry, John
    Lyons, Margaret
    Goldberg, David
    Allen, Elizabeth
    Hickman, Matthew
    ADDICTION, 2011, 106 (11) : 1978 - 1988
  • [6] Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study
    Grebely, J.
    Petoumenos, K.
    Matthews, G. V.
    Haber, P.
    Marks, P.
    Lloyd, A. R.
    Kaldor, J. M.
    Dore, G. J.
    Hellard, M.
    DRUG AND ALCOHOL DEPENDENCE, 2010, 107 (2-3) : 244 - 249
  • [7] Hepatitis C Virus Acquisition among Injecting Drug Users: A Cohort Analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees in Australia, 1995-2004
    Falster, Kathleen
    Kaldor, John M.
    Maher, Lisa
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2009, 86 (01): : 106 - 118
  • [8] Concordance of Ethyl Glucuronide, Blood Alcohol Content, and Self-Reported Alcohol Use in Russian Women with HIV and Hepatitis C Virus Co-Infection
    Brown, Jennifer L.
    Capasso, Ariadna
    Revzina, Natalia
    Boeva, Ekaterina
    Rassokhin, Vadim
    Sales, Jessica M.
    Gutova, Lyudmila V.
    Khalezova, Nadia B.
    Hitch, Anthony E.
    Twitty, T. Dylanne
    DiClemente, Ralph J.
    AIDS AND BEHAVIOR, 2023, 27 (12) : 4062 - 4069
  • [9] Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial
    Grebely, Jason
    Read, Phillip
    Cunningham, Evan B.
    Weltman, Martin
    Matthews, Gail V.
    Dunlop, Adrian
    Montebello, Mark
    Martinello, Marianne
    Gilliver, Rosie
    Marks, Philippa
    Applegate, Tanya L.
    Dore, Gregory J.
    HEALTH SCIENCE REPORTS, 2020, 3 (02)
  • [10] Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study
    Liu, Yin
    Liu, Yu
    Zou, Xia
    Chen, Wen
    Ling, Li
    BMJ OPEN, 2017, 7 (07):